Skip to content
Inciteful Med

Connecting the Dots: Symptoms and the Diagnostic Odyssey

Last updated:

Hypermobile Ehlers-Danlos Syndrome (hEDS) is a multisystemic connective tissue disorder that causes widespread symptoms beyond joint instability. It frequently co-occurs with POTS and MCAS, leading to a complex diagnostic journey where patients are often misdiagnosed with fibromyalgia or anxiety.

Key Takeaways

  • • hEDS is a multisystemic condition that affects connective tissue throughout the entire body, not just the joints.
  • • Many patients experience a trifecta of hEDS, POTS (dysautonomia), and MCAS (mast cell activation), which explains a wide range of overlapping symptoms.
  • • Gastrointestinal issues like acid reflux, gastroparesis, and IBS-like symptoms are common due to overly stretchy tissue in the digestive tract.
  • • Before receiving an accurate hEDS diagnosis, patients are frequently misdiagnosed with conditions like fibromyalgia, chronic fatigue syndrome, or anxiety.
  • • People with hEDS often experience local anesthetic resistance, meaning dental numbing medications may wear off too quickly or fail to work entirely.

Many patients arrive at a diagnosis of Hypermobile Ehlers-Danlos Syndrome (hEDS) after years of wondering why so many different parts of their body seem to be “malfunctioning” at once. Because connective tissue is found almost everywhere, hEDS is a multisystemic condition—meaning it affects far more than just your joints [1][2].

The ‘Trifecta’: hEDS, POTS, and MCAS

Clinicians frequently observe a “triple crown” or “trifecta” of conditions that tend to occur together. While research into the exact biological link is ongoing, many patients find that these three conditions explain the bulk of their symptoms [3][4]:

  1. hEDS/HSD: The underlying connective tissue laxity that causes joint instability and widespread pain [5].
  2. POTS (Postural Orthostatic Tachycardia Syndrome): A form of dysautonomia (malfunction of the autonomic nervous system). It causes your heart rate to jump significantly when you stand up, leading to dizziness, fainting, and “brain fog”, especially when transitioning slowly from sitting to standing or during hot showers [6][7].
  3. MCAS (Mast Cell Activation Syndrome): A condition where your immune cells (mast cells) are “twitchy” and release inflammatory chemicals too easily. This can cause unexplained flushing, hives, nausea, and allergic-like reactions triggered by things like temperature changes, stress, strong fragrances, or specific foods [6][8].

The Digestive Connection

Gastrointestinal (GI) issues are incredibly common, affecting nearly all hEDS patients [9][10]. Because the “glue” holding your digestive tract together is too stretchy, the muscles may not move food through efficiently. Common experiences include:

  • Functional Dyspepsia: Pain or discomfort in the upper stomach, often felt shortly after eating [9].
  • GERD/Reflux: Heartburn caused by the valve at the top of the stomach being too relaxed [11].
  • Gastroparesis: “Stomach paralysis” where the stomach empties too slowly, causing severe nausea and bloating [11].
  • IBS-like symptoms: Frequent bouts of constipation, diarrhea, or abdominal cramping [2][9].

Why You Were Likely Misdiagnosed

Before finding hEDS, most patients receive several other diagnoses. While these conditions may coexist with hEDS, they are often used as “catch-all” labels when a doctor doesn’t recognize the underlying connective tissue disorder [12][6]:

  1. Fibromyalgia: Frequently diagnosed because of widespread pain. hEDS and Fibromyalgia share central sensitization—a state where the nervous system stays in a high-alert “pain mode” [13][14].
  2. Chronic Fatigue Syndrome (ME/CFS): Given due to the profound, bone-deep exhaustion that often accompanies hEDS [6].
  3. Anxiety/Panic Disorder: Physical symptoms of POTS (racing heart, shortness of breath) are often mistaken for panic attacks [1][15].
  4. Functional Neurological Disorder (FND): Diagnosed when neurological symptoms (like tremors or weakness) don’t show up on standard MRIs [12].
  5. Hypochondria: Sadly, many patients are told their symptoms are “all in their head” because standard tests come back normal [1][16].

The Mystery of Local Anesthetics

A unique and frustrating quirk of hEDS is local anesthetic resistance [17]. Many patients report that numbing agents like lidocaine simply “don’t work” or wear off very quickly during dental work or minor surgeries [17][18]. While the exact reason isn’t fully proven, it is suspected that the altered structure of your connective tissue allows the medication to drift away from the nerve too fast, or that your nerves process the signal differently [19][20]. If you have a history of “feeling everything” at the dentist, this may be a key piece of your hEDS puzzle.

Frequently Asked Questions

Why are hEDS, POTS, and MCAS often diagnosed together?
These three conditions are frequently seen together in what is known as the 'trifecta.' While the exact biological link is still being researched, together they explain the widespread joint pain, dizziness upon standing, and unexplained allergic reactions many patients experience.
What digestive issues are associated with hypermobile Ehlers-Danlos syndrome?
Gastrointestinal problems are very common in hEDS because the connective tissue in the digestive tract is too stretchy. This can lead to conditions like acid reflux, delayed stomach emptying (gastroparesis), and symptoms similar to irritable bowel syndrome.
Why is hEDS frequently misdiagnosed as fibromyalgia or anxiety?
Because hEDS causes widespread pain and a racing heart upon standing, standard tests often come back normal. Doctors may misinterpret these systemic connective tissue symptoms as fibromyalgia, chronic fatigue syndrome, or anxiety before recognizing the underlying hypermobility.
Why doesn't numbing medication work well at the dentist if I have hEDS?
Many people with hEDS experience local anesthetic resistance, meaning numbing agents like lidocaine wear off quickly or don't work at all. This is likely because altered connective tissue allows the medication to drift away from the nerves too rapidly.

Questions for Your Doctor

  • • Do my symptoms of dizziness, flushing, and digestive issues suggest the 'trifecta' of hEDS, POTS, and MCAS?
  • • Could my previous diagnosis of fibromyalgia actually be explained by the systemic nature of hEDS?
  • • Given the high rate of local anesthetic resistance in hEDS, should we adjust my pain management for future dental or surgical procedures?
  • • Should I be screened for abdominal compression syndromes like MALS or SMAS due to my post-meal pain?
  • • Can you help me find a physical therapist who understands the difference between strengthening joints and stretching them in hypermobile patients?

Questions for You

  • • When I stand up quickly, do I feel dizzy, see spots, or feel my heart racing?
  • • Do I often have 'unexplained' allergic-like reactions, such as skin flushing, hives, or sudden stomach upset after eating certain foods?
  • • Have I ever needed extra numbing medication at the dentist or during a minor medical procedure?
  • • How many different specialists (GI, cardiology, neurology) have I seen for symptoms that I now realize might be connected?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Self-reported Demographics of 154 Hypermobile Ehlers-Danlos Syndrome Patients.

    Ploeg AN, Courseault J, Cheng WS

    American journal of physical medicine & rehabilitation 2025; (104(10)):927-932 doi:10.1097/PHM.0000000000002766.

    PMID: 40300043
  2. 2

    Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.

    Thwaites PA, Gibson PR, Burgell RE

    Journal of gastroenterology and hepatology 2022; (37(9)):1693-1709 doi:10.1111/jgh.15927.

    PMID: 35750466
  3. 3

    Idiopathic osteoporosis, Ehlers-Danlos syndrome, postural orthostatic tachycardia syndrome, and mast cell activation disorder in a 27-year-old male patient: A unique case presentation.

    Rattray C

    Clinical case reports 2022; (10(5)):e05887 doi:10.1002/ccr3.5887.

    PMID: 35600027
  4. 4

    Autonomic symptom burden, comorbidities and quality of life in women with Hypermobility Spectrum Disorders and hypermobile Ehlers-Danlos syndrome.

    Collins Hutchinson ML, Liang E, Fuster E, Blitshteyn S

    Autonomic neuroscience : basic & clinical 2025; (262()):103356 doi:10.1016/j.autneu.2025.103356.

    PMID: 41118678
  5. 5

    Updates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome

    Forghani I

    Balkan medical journal 2019; (36(1)):12-16 doi:10.4274/balkanmedj.2018.1113.

    PMID: 30063214
  6. 6

    Long COVID and hypermobility spectrum disorders have shared pathophysiology.

    Ganesh R, Munipalli B

    Frontiers in neurology 2024; (15()):1455498 doi:10.3389/fneur.2024.1455498.

    PMID: 39301475
  7. 7

    A new insight on postural tachycardia syndrome in 102 adults with hypermobile Ehlers-Danlos Syndrome/hypermobility spectrum disorder.

    Celletti C, Borsellino B, Castori M, et al.

    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2020; (90(2)) doi:10.4081/monaldi.2020.1286.

    PMID: 32434316
  8. 8

    Mechanisms and management of gastrointestinal symptoms in postural orthostatic tachycardia syndrome.

    Tu Y, Abell TL, Raj SR, Mar PL

    Neurogastroenterology and motility 2020; (32(12)):e14031 doi:10.1111/nmo.14031.

    PMID: 33140561
  9. 9

    Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome.

    Lam CY, Palsson OS, Whitehead WE, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021; (19(2)):277-287.e3 doi:10.1016/j.cgh.2020.02.034.

    PMID: 32109633
  10. 10

    A machine learning approach to stratify patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders according to disorders of gut brain interaction, comorbidities and quality of life.

    Choudhary A, Fikree A, Ruffle JK, et al.

    Neurogastroenterology and motility 2025; (37(1)):e14957 doi:10.1111/nmo.14957.

    PMID: 39543811
  11. 11

    Comprehensive Assessment of Nutrition and Dietary Influences in Hypermobile Ehlers-Danlos Syndrome-A Cross-Sectional Study.

    Topan R, Pandya S, Williams S, et al.

    The American journal of gastroenterology 2024; (119(4)):727-738 doi:10.14309/ajg.0000000000002586.

    PMID: 37970870
  12. 12

    Beyond bones: The relevance of variants of connective tissue (hypermobility) to fibromyalgia, ME/CFS and controversies surrounding diagnostic classification: an observational study.

    Eccles JA, Thompson B, Themelis K, et al.

    Clinical medicine (London, England) 2021; (21(1)):53-58 doi:10.7861/clinmed.2020-0743.

    PMID: 33479068
  13. 13

    Central sensitization as the mechanism underlying pain in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.

    Di Stefano G, Celletti C, Baron R, et al.

    European journal of pain (London, England) 2016; (20(8)):1319-25 doi:10.1002/ejp.856.

    PMID: 26919608
  14. 14

    Perioperative opioid-minimization approach as a useful protocol in the management of patients with Ehlers-Danlos syndrome-hypermobility type, craniocervical instability and severe chronic pain who are to undergo occipito-cervical fixation.

    Ramírez-Paesano C, Rodiera Clarens C, Sharp Segovia A, et al.

    Orphanet journal of rare diseases 2023; (18(1)):214 doi:10.1186/s13023-023-02829-9.

    PMID: 37491286
  15. 15

    The prevalence of hypermobile Ehlers-Danlos syndrome at a gender-affirming primary care clinic.

    Stein T, Collins S, St Louis J

    SAGE open medicine 2025; (13()):20503121251315021 doi:10.1177/20503121251315021.

    PMID: 39850941
  16. 16

    Predictors of pain and mobility disability in the hypermobile Ehlers-Danlos syndrome.

    Kalisch L, Hamonet C, Bourdon C, et al.

    Disability and rehabilitation 2020; (42(25)):3679-3686 doi:10.1080/09638288.2019.1608595.

    PMID: 31060411
  17. 17

    Efficacy of Lidocaine Infusion in the Management of Chronic Myofascial Pain and Intractable Migrainous Headache in a Patient With Hypermobile Ehlers-Danlos Syndrome: A Case Report.

    Sebastian R, Wright T, Lee SJ, Gattu K

    Cureus 2026; (18(2)):e103015 doi:10.7759/cureus.103015.

    PMID: 41798527
  18. 18

    Recognizing and Effectively Managing Hypermobility-Related Conditions.

    Russek LN, Stott P, Simmonds J

    Physical therapy 2019; (99(9)):1189-1200 doi:10.1093/ptj/pzz078.

    PMID: 31158283
  19. 19

    Mitochondrial Dysfunction and Its Potential Molecular Interplay in Hypermobile Ehlers-Danlos Syndrome: A Scoping Review Bridging Cellular Energetics and Genetic Pathways.

    Shirvani P, Shirvani A, Holick MF

    Current issues in molecular biology 2025; (47(2)) doi:10.3390/cimb47020134.

    PMID: 39996855
  20. 20

    An overview of Ehlers Danlos syndrome and the link between postural orthostatic tachycardia syndrome and gastrointestinal symptoms with a focus on gastroparesis.

    Wu W, Ho V

    Frontiers in neurology 2024; (15()):1379646 doi:10.3389/fneur.2024.1379646.

    PMID: 39268060

This page explains the systemic symptoms and common misdiagnoses associated with hEDS for educational purposes. Always consult your healthcare provider for a proper diagnosis and treatment plan.

Stay up to date

Get notified when new research about Hypermobile Ehlers-Danlos Syndrome (hEDS) is published.

No spam. Unsubscribe anytime.